Is Wegovy safe for people with type 2 diabetes?
Wegovy (semaglutide 2.4mg weekly) can be used in adults with type 2 diabetes for weight management, and it is generally considered safe when prescribed and monitored by a clinician, especially within UK weight-management services. It does not usually cause low blood sugar on its own, but the risk of hypos can increase if used alongside insulin or sulfonylureas, so diabetes medicines may need dose adjustments and closer glucose monitoring. People with certain conditions (e.g., significant kidney or liver disease, pregnancy, or a history of pancreatitis) may not be suitable, and individual assessment is important. UK guidance supports Wegovy for weight management in adults with obesity, including some people with type 2 diabetes, when combined with diet, activity, and specialist support.
- Safe for many adults with type 2 diabetes when clinically assessed and monitored.
- Low risk of hypoglycaemia when used alone; risk rises if taken with insulin or sulfonylureas, so doses may need adjusting.
- Not suitable for some people (e.g., pregnancy, certain kidney/liver issues, past pancreatitis) — clinical review required.
- Used for weight management in eligible adults with obesity, including some with type 2 diabetes, alongside lifestyle support.
- Regular follow-up helps manage side effects (e.g., nausea, vomiting) and ensure the medicine fits the diabetes plan.